Anemias Completed Phase 2 Trials for Sotatercept (DB12118)

Also known as: Anemia / Anaemia / Anaemia, unspecified / Unspecified anaemia / Unspecified anemia / Anemia, unspecified / Anaemia NOS

IndicationStatusPhase
DBCOND0031070 (Anemias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01146574A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.Treatment
NCT01999582A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on HemodialysisTreatment